PMID: 2511793Jan 1, 1989Paper

Use of colony-stimulating factors as possible therapeutic agents

Annali Dell'Istituto Superiore Di Sanità
U Testa

Abstract

The first clinical trials have already indicated that long-term administration of recombinant hemopoietic growth factors can be a clinically effective procedure for correcting abnormalities in blood cell formation. Thus, the colony stimulating factors (CSFs) have proved to be highly effective agents in stimulating the formation of granulocytes, monocytes and eosinophils both in animals and man, and in enhancing resistance to otherwise lethal infections. They offer the bright prospect of use in any clinical situation in which the formation or function of these cells is abnormally low (due to the reduced production of myeloid elements such as occurring in aplastic anemias or to the killing of myeloid progenitors and precursors caused by anti-tumor chemotherapy) and causes a real risk of life-threatening infections. From initial clinical trials the CSFs, particularly GM-CSF and G-CSF, can be anticipated to perform effectively in offering the clinician the possibility of active intervention in sustaining myelopoiesis.

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.